Clinical trial
An Intermediate Size Expanded Access Program of Whole, Inactivated SARS-CoV-2 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and Older
NCT05541289 is registered in ClinicalTrials.gov with Ocugen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Intermediate Size Expanded Access Program of Whole, Inactivated SARS-CoV-2 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and Older
- Lead sponsor
- Ocugen
- Phase
- Expanded access
- Overall status
- No longer available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.